131 related articles for article (PubMed ID: 7038420)
1. Vindesine: a phase II study in childhood malignancies-a report for cancer and leukemia group B.
Ettinger LJ; Brecher M; Coleman M; Smithson WA; Patterson R; Russell EC; Necheles T; Jones B; Ohnuma T
Med Pediatr Oncol; 1982; 10(1):35-43. PubMed ID: 7038420
[TBL] [Abstract][Full Text] [Related]
2. Vindesine, prednisone, and daunomycin in acute lymphoblastic leukemia in relapse.
Garay G; Milone J; Dibar E; Pavlovsky S; Kvicala R; Sackmann Muriel F; Montres Varela D; Eppinger-Helft M
Cancer Chemother Pharmacol; 1983; 10(3):224-6. PubMed ID: 6345018
[TBL] [Abstract][Full Text] [Related]
3. [Administration of vindesine sulfate for the treatment of malignant hematological tumors].
Ueda T; Masaoka T; Shibata H; Kubota Y; Saigo K; Kusakabe H; Takubo T; Nakamura H; Yoshitake J; Ishigami S
Gan To Kagaku Ryoho; 1982 Feb; 9(2):306-15. PubMed ID: 6764103
[TBL] [Abstract][Full Text] [Related]
4. [Phase II study of vindesine in hematological malignancies].
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2509-15. PubMed ID: 6580841
[TBL] [Abstract][Full Text] [Related]
5. Vindesine and prednisone for remission induction in children with acute lymphocytic leukemia.
Vats TS; Mehta P; Trueworthy RC; Smith SD; Klopovich P
Cancer; 1981 Jun; 47(12):2789-92. PubMed ID: 6942907
[TBL] [Abstract][Full Text] [Related]
6. [Phase II study of Vindesine in patients with hematological malignancy].
Sampi K; Honda T; Hayashi Y; Hattori M
Gan To Kagaku Ryoho; 1983 Jun; 10(6):1536-7. PubMed ID: 6347082
[TBL] [Abstract][Full Text] [Related]
7. Vindesine in the treatment of refractory hematologic malignancies: a phase II study.
Mandelli F; Amadori S; Giona F; Antonietta M; Spiriti A; Pastore S; Meloni G; Paolucci G
Leuk Res; 1982; 6(5):649-52. PubMed ID: 7154707
[TBL] [Abstract][Full Text] [Related]
8. An initial report of a phase-III trial comparing vindesine and vincristine for acute lymphocytic leukemia of childhood.
Krivit W; Chilcote R; Pyesmany A; Anderson J; Hammond D
Cancer Chemother Pharmacol; 1979; 2(4):267-70. PubMed ID: 287570
[TBL] [Abstract][Full Text] [Related]
9. Phase II evaluation of vindesine in mycosis fungoides, extraosseous plasmacytoma and other hematologic malignancies.
Ferrazzi E; Pappagallo GL; Segati R; Vinante O; Galligioni E; Zagonel V; Salvagno L; Fiorentino MV
Tumori; 1982 Aug; 68(4):321-4. PubMed ID: 7147357
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of vindesine in patients with acute leukemia.
Sklaroff RB; Arlin Z; Young CW
Cancer Treat Rep; 1979; 63(11-12):2063-5. PubMed ID: 294307
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of vindesine in patients with advanced breast cancer.
Walker BK; Raich PC; Fontana J; Subramanian VP; Rogers JS; Knost JA; Denning B
Cancer Treat Rep; 1982 Sep; 66(9):1729-32. PubMed ID: 6288237
[TBL] [Abstract][Full Text] [Related]
12. Phase I evaluation of vindesine in children: a Southwest Oncology Group pilot study.
Komp D; Vats T; Shepherd DA; Vietti T; Hoogstraten B; Haas CD
Med Pediatr Oncol; 1980; 8(3):243-50. PubMed ID: 7193278
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of VM-26 in acute leukemia, neuroblastoma, and other refractory childhood malignancies: a report from the Children's Cancer Study Group.
Bleyer WA; Krivit W; Chard RL; Hammond D
Cancer Treat Rep; 1979 Jun; 63(6):977-81. PubMed ID: 380803
[TBL] [Abstract][Full Text] [Related]
14. [A randomized controlled study on vindesine and vincristine in combination with prednisolone in the treatment of adult acute lymphocytic leukemia and blastic crisis of chronic myeloid leukemia].
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2500-8. PubMed ID: 6580840
[TBL] [Abstract][Full Text] [Related]
15. Sequential combination of methotrexate and vindesine in previously treated children with acute leukemia. A phase I-II study.
Miller LP; Hancock C; Miller DR; Chello PL; Sirotnak FM; Tan CT
Am J Clin Oncol; 1984 Oct; 7(5):465-70. PubMed ID: 6594925
[TBL] [Abstract][Full Text] [Related]
16. Initial clinical study with vindesine: tolerance to weekly iv bolus and 24-hour infusion.
Ohnuma T; Greenspan EM; Holland JF
Cancer Treat Rep; 1980 Jan; 64(1):25-30. PubMed ID: 6929728
[TBL] [Abstract][Full Text] [Related]
17. A study of the cross-resistance of vincristine and vindesine in reinduction therapy for acute lymphocytic leukemia in relapse. A report for Children's Cancer Study Group.
Krivit W; Anderson J; Chilcote R; Pyesmany A; Chard R; Hammond D
Am J Pediatr Hematol Oncol; 1980; 2(3):217-21. PubMed ID: 7001942
[TBL] [Abstract][Full Text] [Related]
18. Vindesine: a new vinca alkaloid.
Bayssas M; Gouveia J; de Vassal F; Misset JL; Schwarzenberg L; Ribaud P; Musset M; Jasmin C; Hayat M; Mathé G
Recent Results Cancer Res; 1980; 74():91-7. PubMed ID: 7003662
[TBL] [Abstract][Full Text] [Related]
19. Vindesine. A review of phase-II trials.
Gralla RJ; Tan CT; Young CW
Cancer Chemother Pharmacol; 1979; 2(4):271-4. PubMed ID: 455587
[TBL] [Abstract][Full Text] [Related]
20. [Phase II study of vindesine in patients with primary bronchogenic carcinoma by Cooperative Study Group].
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1838-43. PubMed ID: 6882007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]